drugset / Trial / NCT06011785

Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil

NCT06011785 ↗

Phase 0 Unknown 100 enrolled HOHM Foundation
NaSingle-groupOpen-labelSupportive care

Summary

This clinical study aims to address a research and clinical treatment gap related to individuals with symptoms of Silicosis resulting from quartzite mining work. Silicosis represents a challenge in this specific population in Sao Thome das Letras, Minas Gerais. Silicosis is a severe disease and is considered incurable. Current conventional medicine only offers palliative care for those with Silicosis, highlighting the important and urgent need for research into complementary care approaches.

Timeline

Start
2024-03-01
Primary completion
2025-03-01
Completion
2026-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Silica 12CH Other / unclassified — —

Indications